3 Stocks Under $50 with Open Questions
3 Stocks Under $50 with Open Questions
3 Small-Cap Stocks That Concern Us
3 Small-Cap Stocks That Concern Us
3 Growth Stocks We Approach with Caution
3 Growth Stocks We Approach with Caution
5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call
5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...
SUPN Q1 Deep Dive: Growth Products Drive Revenue Upside, Guidance Highlights Execution Challenges
SUPN Q1 Deep Dive: Growth Products Drive Revenue Upside, Guidance Highlights Execution Challenges
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges
Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 CY2026 Sales Beat Estimates
Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 CY2026 Sales Beat Estimates